On November 1, Novavax, Inc. (NASDAQ:NVAX) and the U.K. Health Security Agency, representing the U.K. Secretary of State for ...

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...

Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

2 variant, and the Novavax vaccine targets the JN.1 variant—neither of which are the dominant version causing infections in ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

Summer's rise in COVID-19 cases led to the approval of updated versions of vaccinations targeting recent strains for the 2024 ...

The 2024–2025 COVID-19 vaccines are recommended for everyone aged 6 months and older in the US to target the currently circulating SARS-CoV-2 strains, JN.1 and KP.2.

Without explicitly naming the alternative — Novavax — the Sept. 12 guidance appeared to reluctantly endorse that vaccine for ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

Health officials say eligible residents can receive the COVID-19 vaccine at the same time as or at any time before or after ...

The fall booster shot will protect against some of the latest strains of the virus, including JN. 1 and KP. 2, Health Canada ...